Erratum: Targeting the Isoprenoid Pathway in Choleste Biosynthesis: An Approach to Identify Isoprenoid Biosynthesis Inhibitors

IF 3.6 3区医学 Q2 CHEMISTRY, MEDICINAL

Archiv der Pharmazie Pub Date : 2025-05-21 DOI:10.1002/ardp.70016

引用次数: 0

Abstract

by Maximilian Liebl, Florian Olander, Christoph Müller

In the title of the article published as Arch. Pharm. 2025;358:e2400807, https://doi.org/10.1002/ardp.202400807, the word cholesterol was misrepresented as cholestero. The correct title is:

Targeting the isoprenoid pathway in cholesterol biosynthesis: An approach to identify isoprenoid biosynthesis inhibitors

查看原文本刊更多论文

在胆石生物合成中靶向类异戊二烯途径：一种鉴定类异戊二烯生物合成抑制剂的方法

作者：Maximilian Liebl， Florian Olander, Christoph m以Arch作为文章的标题发表。Pharm. 2025;358:e2400807, https://doi.org/10.1002/ardp.202400807，“胆固醇”这个词被误写成了“胆固醇”。正确的标题是：靶向胆固醇生物合成中的类异戊二烯途径：一种鉴定类异戊二烯生物合成抑制剂的方法

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Archiv der Pharmazie 医学-化学综合

CiteScore

7.90

自引率

5.90%

发文量

176

审稿时长

3.0 months

期刊介绍： Archiv der Pharmazie - Chemistry in Life Sciences is an international journal devoted to research and development in all fields of pharmaceutical and medicinal chemistry. Emphasis is put on papers combining synthetic organic chemistry, structural biology, molecular modelling, bioorganic chemistry, natural products chemistry, biochemistry or analytical methods with pharmaceutical or medicinal aspects such as biological activity. The focus of this journal is put on original research papers, but other scientifically valuable contributions (e.g. reviews, minireviews, highlights, symposia contributions, discussions, and essays) are also welcome.